Delaware | 001-37792 | 27-3019889 | ||||||||||||
(State or other jurisdiction of
incorporation) |
(Commission File Number) |
(IRS Employer
Identification No.) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Common Stock, par value $0.0001 per share | NH | The Nasdaq Stock Market LLC |
Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Name and Principal Position(1)
|
Year |
Salary
($)(2) |
Bonus
($)(2) |
Stock
Awards ($)(3) |
Option
Awards ($)(4) |
All Other
Compensation ($) |
Total
($) |
||||||||||||||||||||||||||||||||||||||||
Patrick Soon-Shiong, M.D.
FRCS (C), FACS(5) |
2020 | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Chairman and Chief Executive Officer | 2019 | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Bob Petrou | 2020 | 355,302 | 102,778 | — | 1,220,000 |
18,214(6)
|
1,696,294 | ||||||||||||||||||||||||||||||||||||||||
Chief Financial Officer | 2019 | 323,231 | 181,473 | 177,982 | — |
2,388(7)
|
685,074 | ||||||||||||||||||||||||||||||||||||||||
Ron Louks | 2020 | 471,096 | 210,276 | — | 1,586,000 |
99,292(8)
|
2,366,664 | ||||||||||||||||||||||||||||||||||||||||
Chief Operating Officer | 2019 | 450,000 | 195,075 | 176,351 | — |
106,903(9)
|
928,329 |
(1) | The titles and capacities set forth in the table above are as of the April 20, 2021. | ||||
(2) | Salary and bonus figures represent amounts earned during each respective fiscal year, regardless of whether part or all of such amounts were paid in subsequent fiscal year(s). | ||||
(3) |
The amounts shown are total vested and unvested stock awards granted during the respective years at grant date fair value in accordance with Accounting Standards Codification 718, Compensation–Stock Compensation. The assumptions used to calculate the grant date fair value of stock awards are set forth under Note 2 of the Notes to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 26, 2021.
|
||||
(4) | The amounts shown are total vested and unvested option awards granted during the respective years at grant date fair value in accordance with the Black-Scholes option-pricing model based on the closing price of our common stock on the Nasdaq Stock Market LLC on the date of grant. | ||||
(5) | We did not pay cash or any other compensation to Dr. Patrick Soon-Shiong during the years ended December 31, 2020 or December 31, 2019. | ||||
(6) | Consists of $8,550 of 401(k) matching contributions paid by the Company, $2,642 of life and disability insurance payments, and $7,021 of healthcare benefits. | ||||
(7) | Consists of $2,388 of life and disability insurance payments. | ||||
(8) | Consists of a $60,461 housing allowance including $15,685 of associated tax gross-up paid by the Company in connection with the travel and housing allowances, $8,550 of 401(k) matching contributions paid by the company, $6,549 of life and disability insurance payments, and $23,732 of healthcare benefits. | ||||
(9) | Consists of $71,985 of travel and housing allowances, including $19,009 of associated tax gross-up paid by the Company in connection with the travel and housing allowances, $8,360 of 401(k) matching contributions paid by the Company and $26,558 of healthcare and other benefits. | ||||
NantHealth, Inc. | |||||||||||
Date: | May 18, 2021 | By: | /s/ Bob Petrou | ||||||||
Bob Petrou | |||||||||||
Chief Financial Officer |